Corvus Pharmaceuticals to Host Investor and Analyst Meeting on May 14, 2026 to Highlight Soquelitinib Data Being Presented at the Society for Investigative Dermatology (SID) Annual Meeting
Go back to Corvus Pharmaceuticals to Host Investor and Analyst Meeting on May 14, 2026 to Highlight Soquelitinib Data Being Presented at the Society for Investigative Dermatology (SID) Annual Meeting| (NASDAQ: CRVS) | Delayed: 12.63 +0.07 (0.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.56 | 52 Week High | $17.77 | |||
| Open | $12.10 | 52 Week Low | $9.63 | |||
| Day High | $13.07 | P/E | N/A | |||
| Day Low | $12.09 | EPS | $0.00 | |||
| Volume | 920,048 | |||||
